Détail de l'auteur
Documents disponibles écrits par cet auteur
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) Mettre toutes les notices dans le panier Faire une suggestion Ajouter un critère de recherche
Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study
Lim J, Eftimov F, Verhamme C, et al.
Rheumatology (Oxford, England), 2020
Characterization of EEG-based functional brain networks in myotonic dystrophy type 1
Biere J, Okkersen K, van Alfen N, et al.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2020, 131, 8, p 1886
Inclusion body myositis in patients with spinocerebellar ataxia types 3 and 6
Rietveld A, van Gaalen J, Saris C, et al.
Journal of neurology, neurosurgery, and psychiatry, 2020
Comment on "Systematic retrospective study on 64 patients anti-Mi2 dermatomyositis: a classic skin rash with a necrotizing myositis and high risk of malignancy"
Lim J, Raaphorst J, van der Kooi AJ
Journal of the American Academy of Dermatology, 2020
Response to the letter to editor about "Affective symptoms and apathy in myotonic dystrophy type 1 a systematic review and meta-analysis"
Okkersen K, Raaphorst J
Journal of affective disorders, 2019, 259, p 468
High incidence of falls in patients with myotonic dystrophy type 1 and 2: A prospective study
Berends J, Tieleman AA, Horlings CGC, et al.
Neuromuscular disorders : NMD, 2019
Affective symptoms and apathy in myotonic dystrophy type 1 a systematic review and meta-analysis
van der Velden BG, Okkersen K, Kessels RP, et al.
Journal of affective disorders, 2019, 250, p 260
Experiences with bariatric surgery in patients with facioscapulohumeral dystrophy and myotonic dystrophy type 1: A qualitative study.
Abel EEDH, Cup EHC, Lanser A, et al.
Neuromuscular disorders : NMD, 2018, p. 938
Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands
Stunnenberg BC, Raaphorst J, Deenen JCW, et al.
Neuromuscular disorders : NMD, 2018
Falls and resulting fractures in Myotonic Dystrophy: Results from a multinational retrospective survey
Jimenez-Moreno AC, Raaphorst J, Babacic H, et al.
Neuromuscular disorders : NMD, 2017
The cognitive profile of myotonic dystrophy type 1: A systematic review and meta-analysis
Okkersen K, Buskes M, Groenewoud J, et al.
Cortex; a journal devoted to the study of the nervous system and behavior, 2017, 95, p 143
Brain imaging in myotonic dystrophy type 1: A systematic review.
Okkersen K, Monckton DG, Le N, et al.
Neurology, 2017, 89, 9, p 960
Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol
Stunnenberg BC, Woertman W, Raaphorst J, et al.
BMC neurology, 2015, 15
RYR1-related myopathies: a wide spectrum of phenotypes throughout life
Snoeck M, van Engelen BG, Küsters B, et al.
European journal of neurology : the official journal of the European Federation of Neurological Societies, 2015, 22, 7, p 1094
Prefrontal involvement related to cognitive impairment in progressive muscular atrophy
Raaphorst J, van Tol MJ, Groot PF, et al.
Neurology, 2014, 83, 9, p 818
